β-Secretase Activity Increases with Aging in Human, Monkey, and Mouse Brain

Correlative Memory Deficits, Aβ Elevation, and Amyloid Plaques in Transgenic Mice

Hsiao, K., Chapman, P., Nilsen, S., Eckman, C., Harigaya, Y., Younkin, S., Yang, F., & Cole, G. (1996) · Science · doi:10.1126/science.274.5284.99 · Cited by 4,210

β-Secretase Cleavage of Alzheimer's Amyloid Precursor Protein by the Transmembrane Aspartic Protease BACE

Vassar, R., Bennett, B. D., Babu-Khan, S., Kahn, S., Mendiaz, E. A., Denis, P., Teplow, D. B., Ross, S., Amarante, P., Loeloff, R., et al. (1999) · Science · doi:10.1126/science.286.5440.735 · Cited by 3,876

Secreted amyloid β–protein similar to that in the senile plaques of Alzheimer's disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer's disease

Scheuner, D., Eckman, C., Jensen, M., Song, X., Citron, M., Suzuki, N., Bird, T. D., Hardy, J., Hutton, M., Kukull, W., et al. (1996) · Nature Medicine · doi:10.1038/nm0896-864 · Cited by 2,599

Alzheimer-type neuropathology in transgenic mice overexpressing V717F β-amyloid precursor protein

Games, D., Adams, D., Alessandrini, R., Barbour, R., Borthelette, P., Blackwell, C., Carr, T., Clemens, J., Donaldson, T., Gillespie, F., et al. (1995) · Nature · doi:10.1038/373523a0 · Cited by 2,516

Editorial on Consensus Recommendations for the Postmortem Diagnosis of Alzheimer Disease from the National Institute on Aging and the Reagan Institute Working Group on Diagnostic Criteria for the Neuropathological Assessment of Alzheimer Disease

HYMAN, B. T., & TROJANOWSKI, J. Q. (1997) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/00005072-199710000-00002 · Cited by 1,542

Two amyloid precursor protein transgenic mouse models with Alzheimer disease-like pathology

Sturchler-Pierrat, C., Abramowski, D., Duke, M., Wiederhold, K.-H., Mistl, C., Rothacher, S., Ledermann, B., Bürki, K., Frey, P., Paganetti, P. A., et al. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.24.13287 · Cited by 1,507

An Increased Percentage of Long Amyloid β Protein Secreted by Familial Amyloid β Protein Precursor (βApp 717 ) Mutants

Suzuki, N., Cheung, T. T., Cai, X.-D., Odaka, A., Otvos, L., Eckman, C., Golde, T. E., & Younkin, S. G. (1994) · Science · doi:10.1126/science.8191290 · Cited by 1,471

The prevalence of dementia: A quantitative integration of the literature

Jorm, A. F., Korten, A. E., & Henderson, A. S. (1987) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1987.tb02906.x · Cited by 1,301

Mice deficient in BACE1, the Alzheimer's β-secretase, have normal phenotype and abolished β-amyloid generation

Luo, Y., Bolon, B., Kahn, S., Bennett, B. D., Babu-Khan, S., Denis, P., Fan, W., Kha, H., Zhang, J., Gong, Y., et al. (2001) · Nature Neuroscience · doi:10.1038/85059 · Cited by 1,001

The distribution of tangles, plaques and related immunohistochemical markers in healthy aging and Alzheimer's disease

Price, J. L., Davis, P. B., Morris, J. C., & White, D. L. (1991) · Neurobiology of Aging · doi:10.1016/0197-4580(91)90006-6 · Cited by 818

BACE2 Expression Increases in Human Neurodegenerative Disease

Holler, C. J., Webb, R. L., Laux, A. L., Beckett, T. L., Niedowicz, D. M., Ahmed, R. R., Liu, Y., Simmons, C. R., Dowling, A. L. S., Spinelli, A., et al. (2011) · American Journal Of Pathology · doi:10.1016/j.ajpath.2011.09.034 · Cited by 66

Increased BACE1 maturation contributes to the pathogenesis of Alzheimer's disease in Down syndrome

Sun, X., Tong, Y., Qing, H., Chen, C.-H., & Song, W. (2006) · The FASEB Journal · doi:10.1096/fj.05-5628com · Cited by 64

Melatonin administration reverses the alteration of amyloid precursor protein-cleaving secretases expression in aged mouse hippocampus

Mukda, S., Panmanee, J., Boontem, P., & Govitrapong, P. (2016) · Neuroscience Letters · doi:10.1016/j.neulet.2016.04.013 · Cited by 62

miR-124 downregulates BACE 1 and alters autophagy in APP/PS1 transgenic mice

Du, X., Huo, X., Yang, Y., Hu, Z., Botchway, B. O. A., Jiang, Y., & Fang, M. (2017) · Toxicology Letters · doi:10.1016/j.toxlet.2017.08.082 · Cited by 64

BACE1 as a Potential Biomarker for Alzheimer's Disease

Decourt, B., & Sabbagh, M. N. (2011) · Journal of Alzheimer s Disease · doi:10.3233/jad-2011-110017 · Cited by 62

BACE1 as a Therapeutic Target in Alzheimer’s Disease: Rationale and Current Status

Evin, G. M., & Hince, C. (2013) · Drugs & Aging · doi:10.1007/s40266-013-0099-3 · Cited by 60

Biochemical deficits and cognitive decline in brain aging: Intervention by dietary supplements

Poddar, J., Pradhan, M., Ganguly, G., & Chakrabarti, S. (2018) · Journal of Chemical Neuroanatomy · doi:10.1016/j.jchemneu.2018.04.002 · Cited by 63

Enhancement of BACE1 Activity by p25/Cdk5-Mediated Phosphorylation in Alzheimer’s Disease

Song, W.-J., Son, M.-Y., Lee, H.-W., Seo, H., Kim, J. H., & Chung, S.-H. (2015) · PLOS ONE · doi:10.1371/journal.pone.0136950 · Cited by 50

Protease inhibitors as potential disease-modifying therapeutics for Alzheimer’s disease

Beher, D., & Graham, S. L. (2005) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.14.11.1385 · Cited by 61

Alzheimer's disease--a dysfunction in cholesterol and lipid metabolism

Lukiw, W. J., Pappolla, M., Pelaez, R. P., & Bazan, N. G. (2005) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-005-4010-6 · Cited by 59

Trafficking of Alzheimer's Disease–Related Membrane Proteins and Its Participation in Disease Pathogenesis

Suzuki, T., Araki, Y., Yamamoto, T., & Nakaya, T. (2006) · The Journal of Biochemistry · doi:10.1093/jb/mvj121 · Cited by 60

Natural Compounds with Anti-BACE1 Activity as Promising Therapeutic Drugs for Treating Alzheimerʼs Disease

Naushad, M., Durairajan, S. S. K., Bera, A. K., Senapati, S., & Li, M. (2019) · Planta Medica · doi:10.1055/a-1019-9819 · Cited by 59

Upregulation of APP endocytosis by neuronal aging drives amyloid-dependent synapse loss

Burrinha, T., Martinsson, I., Gomes, R., Terrasso, A. P., Gouras, G. K., & Almeida, C. G. (2021) · Journal of Cell Science · doi:10.1242/jcs.255752 · Cited by 64

Functions of the Alzheimer’s Disease Protease BACE1 at the Synapse in the Central Nervous System

Munro, K. M., Nash, A., Pigoni, M., Lichtenthaler, S. F., & Gunnersen, J. M. (2016) · Journal of Molecular Neuroscience · doi:10.1007/s12031-016-0800-1 · Cited by 59

Increased CSF Aβ during the very early phase of cerebral Aβ deposition in mouse models

Maia, L. F., Kaeser, S. A., Reichwald, J., Lambert, M., Obermüller, U., Schelle, J., Odenthal, J., Martus, P., Staufenbiel, M., & Jucker, M. (2015) · EMBO Molecular Medicine · doi:10.15252/emmm.201505026 · Cited by 55

Discovery of polymethoxyflavones from black ginger ( Kaempferia parviflora ) as potential β-secretase (BACE1) inhibitors

Youn, K., Lee, J., Ho, C., & Jun, M. (2015) · Journal of Functional Foods · doi:10.1016/j.jff.2015.10.036 · Cited by 53

Neuronal and Nonneuronal Quantitative BACE Immunocytochemical Expression in the Entorhinohippocampal and Frontal Regions in Alzheimer’s Disease

Leuba, G., Wernli, G., Vernay, A., Kraftsik, R., Mohajeri, M. H., & Saini, K. (2005) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000083496 · Cited by 52

Gender dependent APP processing in a transgenic mouse model of Alzheimer’s disease

Schäfer, S., Wirths, O., Multhaup, G., & Bayer, T. A. (2006) · Journal of Neural Transmission · doi:10.1007/s00702-006-0580-9 · Cited by 52

Consequences of Pharmacological BACE Inhibition on Synaptic Structure and Function

Zhu, K., Peters, F., Filser, S., & Herms, J. W. (2018) · Biological Psychiatry · doi:10.1016/j.biopsych.2018.04.022 · Cited by 52

New insights into the role of glycogen synthase kinase-3 in Alzheimer's disease

Medina, M., & Ávila, J. (2013) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2013.843670 · Cited by 50

Alzheimer’s therapy targeting the β-secretase enzyme BACE1: Benefits and potential limitations from the perspective of animal model studies

Ohno, M. (2016) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2016.04.007 · Cited by 51

Statins inhibit the dimerization of β-secretase via both isoprenoid- and cholesterol-mediated mechanisms

Parsons, R. B., Price, G. C., Farrant, J. K., Subramaniam, D., Adeagbo-Sheikh, J., & Austen, B. (2006) · Biochemical Journal · doi:10.1042/bj20060655 · Cited by 50

APPandBACE1miRNA genetic variability has no major role in risk for Alzheimer disease

Bettens, K., Brouwers, N., Engelborghs, S., Miegroet, H. V., Deyn, P. P. D., Theuns, J., Sleegers, K., & Broeckhoven, C. V. (2009) · Human Mutation · doi:10.1002/humu.21027 · Cited by 50

Sensorimotor gating and memory deficits in an APP/PS1 double transgenic mouse model of Alzheimer's disease

Wang, H., He, J., Zhang, R., Zhu, S., Wang, J., Kong, L., Tan, Q., & Li, X. (2012) · Behavioural Brain Research · doi:10.1016/j.bbr.2012.05.007 · Cited by 50

Early Molecular Changes in Alzheimer Disease: Can We Catch the Disease in its Presymptomatic Phase?

Wirz, K. T. S., Keitel, S., Swaab, D. F., Verhaagen, J., & Bossers, K. (2013) · Journal of Alzheimer s Disease · doi:10.3233/jad-130920 · Cited by 47

Salidroside attenuates hypoxia-induced abnormal processing of amyloid precursor protein by decreasing BACE1 expression in SH-SY5Y cells

Li, Q.-Y., Wang, H.-M., Wang, Z., Ma, J., Ding, J., & Chen, S.-D. (2010) · Neuroscience Letters · doi:10.1016/j.neulet.2010.06.076 · Cited by 45

Elevated amyloid β production in senescent retinal pigment epithelium, a possible mechanism of subretinal deposition of amyloid β in age-related macular degeneration

Wang, J., Ohno‐Matsui, K., & Morita, I. (2012) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2012.05.085 · Cited by 46

Leukotriene D4 induces amyloid-β generation via CysLT1R-mediated NF-κB pathways in primary neurons

Wang, X. Y., Tang, S. S., Hu, M. Y., Long, Y., Li, Y. Q., Liao, M. X., Ji, H., & Hong, H. (2013) · Neurochemistry International · doi:10.1016/j.neuint.2013.01.002 · Cited by 46

Biomarkers of ageing of humans and non-human primates

Wu, Z., Qu, J. T., Zhang, W., Bao, Z., Bi, Y., Cai, J.-P., Cai, S.-Q., Cao, C.-M., Cao, F., Cao, Z., et al. (2025) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-025-00883-8 · Cited by 52

Tau deletion reduces plaque‐associated BACE1 accumulation and decelerates plaque formation in a mouse model of Alzheimer's disease

Peters, F., Salihoglu, H., Pratsch, K., Herzog, É., Pigoni, M., Sgobio, C., Lichtenthaler, S. F., Neumann, U., & Herms, J. W. (2019) · The EMBO Journal · doi:10.15252/embj.2019102345 · Cited by 44

Prion Protein is Reduced in Aging and in Sporadic but not in Familial Alzheimer's Disease

Whitehouse, I. J., Jackson, C. D., Turner, A. J., & Hooper, N. M. (2010) · Journal of Alzheimer s Disease · doi:10.3233/jad-2010-101071 · Cited by 43

Proteins Involved in Endocytosis Are Upregulated by Ageing in the Normal Human Brain: Implications for the Development of Alzheimer’s Disease

Alsaqati, M., Thomas, R. S., & Kidd, E. J. (2018) · The Journals of Gerontology: Series A · doi:10.1093/gerona/glx135 · Cited by 43

Prion Protein Is Decreased in Alzheimer's Brain and Inversely Correlates with BACE1 Activity, Amyloid-β Levels and Braak Stage

Whitehouse, I. J., Miners, J. S., Glennon, E. B. C., Kehoe, P. G., Love, S., Kellett, K. A. B., & Hooper, N. M. (2013) · PLoS ONE · doi:10.1371/journal.pone.0059554 · Cited by 43

Cognitive aging and Alzheimer’s disease

Vandenberghe, R. R., & Tournoy, J. (2005) · Postgraduate Medical Journal · doi:10.1136/pgmj.2004.028290 · Cited by 45

The silence of the fats: A MAM’s story about Alzheimer

Agrawal, R. R., Montesinos, J., Larrea, D., Área-Gómez, E., & Pera, M. (2020) · Neurobiology of Disease · doi:10.1016/j.nbd.2020.105062 · Cited by 42

BACE1 Inhibitors for Alzheimer’s Disease: Current Challenges and Future Perspectives

Coimbra, J. R. M., Resende, R., Custódio, J. B. A., Salvador, J. A. R., & Santos, A. E. (2024) · Journal of Alzheimer s Disease · doi:10.3233/jad-240146 · Cited by 43

Higher Soluble Amyloid β Concentration in Frontal Cortex of Young Adults than in Normal Elderly or Alzheimer's Disease

Helmond, Z. V., Miners, J. S., Kehoe, P. G., & Love, S. (2010) · Brain Pathology · doi:10.1111/j.1750-3639.2010.00374.x · Cited by 42

Oxidative Stress and Natural Antioxidants: Back and Forth in the Neurological Mechanisms of Alzheimer’s Disease

Mani, S., Dubey, R., Lai, I., Babu, M. A., Tyagi, S., Swargiary, G., Mody, D., Singh, M., Agarwal, S., Iqbal, D., et al. (2023) · Journal of Alzheimer s Disease · doi:10.3233/jad-220700 · Cited by 43

Oxidation of ion channels in the aging nervous system

Patel, R., & Sesti, F. (2016) · Brain Research · doi:10.1016/j.brainres.2016.02.046 · Cited by 41

Phlorotannin-rich Ecklonia cava reduces the production of beta-amyloid by modulating alpha- and gamma-secretase expression and activity

Kang, I., Jang, B. G., In, S., Choi, B., Kim, M., & Kim, M.-J. (2012) · NeuroToxicology · doi:10.1016/j.neuro.2012.09.013 · Cited by 39

Allicin ameliorates cognitive impairment in APP/PS1 mice via Suppressing oxidative stress by Blocking JNK Signaling Pathways

Zhang, H., Wang, P., Xue, Y., Liu, L., Li, Z., & Liu, Y. (2017) · Tissue and Cell · doi:10.1016/j.tice.2017.11.002 · Cited by 39

Does the Genetic Feature of the Chinese Tree Shrew ( Tupaia belangeri chinensis ) Support Its Potential as a Viable Model for Alzheimer’s Disease Research?

Fan, Y., Luo, R., Su, L., Xiang, Q., Yu, D., Xu, L., Chen, J., Bi, R., Wu, D., Zheng, P., et al. (2018) · Journal of Alzheimer s Disease · doi:10.3233/jad-170594 · Cited by 37

Memory and learning impairment induced by dexamethasone in senescent but not young mice

Yao, Y., Liu, D., Xu, D.-F., & Li, W. (2007) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2007.07.021 · Cited by 40

Beneficial effects of quetiapine in a transgenic mouse model of Alzheimer's disease

He, J., Luo, H., Yan, B., Yu, Y., Wang, H., Wei, Z., Zhang, Y., Xu, H., Tempier, A., Li, X., et al. (2008) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2007.11.001 · Cited by 37

Filling the void: a role for exercise-induced BDNF and brain amyloid precursor protein processing

MacPherson, R. E. K. (2017) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00255.2017 · Cited by 41

Modulators of γ-Secretase Activity Can Facilitate the Toxic Side-Effects and Pathogenesis of Alzheimer's Disease

Svedružić, Ž. M., Popović, K., & Jengić, V. Š. (2013) · PLoS ONE · doi:10.1371/journal.pone.0050759 · Cited by 35

Biological basis for amyloidogenesis in Alzheimer’S disease

Андреева, Т. В., Lukiw, W. J., & Rogaev, E. I. (2017) · Biochemistry (Moscow) · doi:10.1134/s0006297917020043 · Cited by 38

The Oral Iron Chelator, Deferasirox, Reverses the Age-Dependent Alterations in Iron and Amyloid-β Homeostasis in Rat Brain: Implications in the Therapy of Alzheimer’s Disease

Banerjee, P., Sahoo, A., Anand, S., Bir, A., & Chakrabarti, S. (2015) · Journal of Alzheimer s Disease · doi:10.3233/jad-150514 · Cited by 37

Expression of Amyloid-Associated miRNAs in Both the Forebrain Cortex and Hippocampus of Middle-Aged Rat

Che, H., Sun, L.-H., Guo, F., Niu, H.-F., Su, X.-L., Bao, Y.-N., Fu, Z. D., Liu, H.-L., Hou, X., Yang, B.-F., et al. (2014) · Cellular Physiology and Biochemistry · doi:10.1159/000356646 · Cited by 35

Early Growth Response 1 (Egr-1) Is a Transcriptional Activator of β-Secretase 1 (BACE-1) in the Brain

Qin, X., Wang, Y., & Paudel, H. K. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.738849 · Cited by 33

Surgery Performed Under Propofol Anesthesia Induces Cognitive Impairment and Amyloid Pathology in ApoE4 Knock-In Mouse Model

Kim, J. H., Jung, H., Lee, Y., & Sohn, J. (2021) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2021.658860 · Cited by 33

Partial reduction of amyloid β production by β-secretase inhibitors does not decrease synaptic transmission

Şatır, T. M., Agholme, L., Karlsson, A., Karlsson, M., Karila, P., Illes, S., Bergström, P., & Zetterberg, H. (2020) · Alzheimer s Research & Therapy · doi:10.1186/s13195-020-00635-0 · Cited by 33

Brain Aβ load association and sexual dimorphism of plasma BACE1 concentrations in cognitively normal individuals at risk for AD

Vergallo, A., Houot, M., Cavedo, E., Lemercier, P., Vanmechelen, E., De Vos, A., Habert, M., Potier, M., Dubois, B., Lista, S., et al. (2019) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2019.07.001 · Cited by 32

β‐secretase expression in normal and functionally deprived rat olfactory bulbs: Inverse correlation with oxidative metabolic activity

Yan, X., Xiong, K., Luo, X., Struble, R. G., & Clough, R. W. (2007) · The Journal of Comparative Neurology · doi:10.1002/cne.21239 · Cited by 31

MAM and C99, key players in the pathogenesis of Alzheimer’s disease

Pera, M., Montesinos, J., Larrea, D., Agrawal, R. R., VELASCO, K. R., Stavrovskaya, I. G., Yun, T. D., & Área-Gómez, E. (2020) · International review of neurobiology · doi:10.1016/bs.irn.2020.03.016 · Cited by 35

Hyperbaric oxygen therapy restores cognitive function and hippocampal pathologies in both aging and aging-obese rats

Shwe, T., Bo‐Htay, C., Ongnok, B., Chunchai, T., Jaiwongkam, T., Kerdphoo, S., Kumfu, S., Pratchayasakul, W., Pattarasakulchai, T., Chattipakorn, N., et al. (2021) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2021.111465 · Cited by 32

Adult‐Onset Hypothyroidism Induces the Amyloidogenic Pathway of Amyloid Precursor Protein Processing in the Rat Hippocampus

Ghenimi, N., Alfos, S., Redonnet, A., Higueret, P., Pallet, V., & Enderlin, V. (2010) · Journal of Neuroendocrinology · doi:10.1111/j.1365-2826.2010.02002.x · Cited by 31

Age-associated changes in amyloid-β and formaldehyde concentrations in cerebrospinal fluid of rhesus monkeys

Li, Z.-H., 650223，中国, 中. 昆., He, X., Li, H., He, R., Hu, X., 650204，中国, 中. 昆., 671000，中国, 大. 大., 200031，中国, 中., 650223，中国, 中. 昆., et al. (2020) · 动物学研究 · doi:10.24272/j.issn.2095-8137.2020.088 · Cited by 32

Accumulation of Insoluble Amyloid-β in Down's Syndrome is Associated with Increased BACE-1 and Neprilysin Activities

Miners, J., Morris, S., Love, S., & Kehoe, P. (2011) · Journal of Alzheimer's Disease · doi:10.3233/jad-2010-101395 · Cited by 32

Neurosecretases provide strategies to treat sporadic and familial Alzheimer disorders

Marks, N., & Berg, M. J. (2007) · Neurochemistry International · doi:10.1016/j.neuint.2007.06.020 · Cited by 30

Trafficking in neurons: Searching for new targets for Alzheimer's disease future therapies

Musardo, S., Saraceno, C., Pelucchi, S., & Marcello, E. E. (2013) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2013.07.019 · Cited by 29

Is It the Twilight of BACE1 Inhibitors?

Hrabinova, M., Pejchal, J., Kucera, T., Jun, D., Schmidt, M., & Soukup, O. (2020) · Current Neuropharmacology · doi:10.2174/1570159x18666200503023323 · Cited by 28

Widespread distribution of reticulon-3 in various neurodegenerative diseases

Heath, J. E., Siedlak, S. L., Zhu, X., Lee, H., Thakur, A., Yan, R., Perry, G. L., Smith, M. A., & Castellani, R. J. (2010) · Neuropathology · doi:10.1111/j.1440-1789.2010.01107.x · Cited by 29

Cytokines and Cytokine Receptors Involved in the Pathogenesis of Alzheimers Disease

Nagae, T., & Araki, K. (2016) · Journal of Clinical & Cellular Immunology · doi:10.4172/2155-9899.1000441 · Cited by 28

Environmental exposures and the etiopathogenesis of Alzheimer's disease: The potential role of BACE1 as a critical neurotoxic target

Syeda, T., & Cannon, J. R. (2021) · Journal of Biochemical and Molecular Toxicology · doi:10.1002/jbt.22694 · Cited by 30

Unmasking BACE1 in aging and age-related diseases

Bao, H., & Shen, Y. (2022) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2022.11.008 · Cited by 28

Does Alzheimer's disease exist in all primates? Alzheimer pathology in non-human primates and its pathophysiological implications (I)

Tolédano, A., Álvarez, M. I., López-Rodríguez, A. B., Toledano‐Díaz, A., & Fernández, C. I. (2012) · Neurología (English Edition) · doi:10.1016/j.nrleng.2012.07.002 · Cited by 29

Aβ aggregation profiles and shifts in APP processing favor amyloidogenesis in canines

Pop, V., Head, E., Berchtold, N. C., Glabe, C. G., Studzinski, C. M., Weidner, A. M., Murphy, M. P., & Cotman, C. W. (2010) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2010.02.008 · Cited by 31

Aging impact on amyloid precursor protein neuronal trafficking

Burrinha, T., & Guimas Almeida, C. (2022) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2022.102524 · Cited by 26

Sex-Specific Regulation of β-Secretase: A Novel Estrogen Response Element (ERE)-Dependent Mechanism in Alzheimer's Disease

Cui, J., Ait‐Ghezala, G., Sambamurti, K., Gao, F., Shen, Y., & Li, R. (2021) · Journal of Neuroscience · doi:10.1523/jneurosci.0864-20.2021 · Cited by 26

Design and characterization of a new cell‐permeant inhibitor of the β‐secretase BACE1

Lefranc‐Jullien, S., Lisowski, V., Hernandez, J., Martínez, J., & Checler, F. (2005) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0706183 · Cited by 26

Toward modeling hemorrhagic and encephalitic complications of Alzheimer amyloid-β vaccination in nonhuman primates

Gandy, S., & Walker, L. C. (2004) · Current Opinion in Immunology · doi:10.1016/j.coi.2004.08.002 · Cited by 27

Impaired autophagy in amyloid-beta pathology: A traditional review of recent Alzheimer's research

Yuan, M., Wang, Y., Huang, Z., Jing, F., Qiao, P., Zou, Q., Li, J., & Cai, Z. (2022) · Journal of Biomedical Research · doi:10.7555/jbr.36.20220145 · Cited by 26

Amyloid futures in the expanding pathology of brain aging and dementia

Thorwald, M. A., Silva, J. A., Head, E., & Finch, C. E. (2022) · Alzheimer s & Dementia · doi:10.1002/alz.12896 · Cited by 24

BACE Inhibitors for the Treatment of Alzheimer's Disease

Baxter, E. W., & Reitz, A. B. (2005) · Annual reports in medicinal chemistry · doi:10.1016/s0065-7743(05)40003-2 · Cited by 25

β -Secretases, Alzheimer’s Disease, and Down Syndrome

Webb, R. L., & Murphy, M. P. (2012) · Current Gerontology and Geriatrics Research · doi:10.1155/2012/362839 · Cited by 26

Pharmacological evaluation of bromelain in mouse model of Alzheimer’s disease

Kumar, R., Kumar, R., Sharma, N., Khurana, N., Singh, S. K., Satija, S., Mehta, M., & Vyas, M. (2022) · NeuroToxicology · doi:10.1016/j.neuro.2022.02.009 · Cited by 24

The Pursuit of the “Inside” of the Amyloid Hypothesis—Is C99 a Promising Therapeutic Target for Alzheimer’s Disease?

Takasugi, N., Komai, M., Kaneshiro, N., Ikeda, A., Kamikubo, Y., & Uehara, T. (2023) · Cells · doi:10.3390/cells12030454 · Cited by 29

BACE 2 degradation mediated by the macroautophagy–lysosome pathway

Liu, X., Wang, Z., Wu, Y., Wang, J., & Song, W. (2013) · European Journal of Neuroscience · doi:10.1111/ejn.12204 · Cited by 24

Differential regulation of insulin signalling by monomeric and oligomeric amyloid beta-peptide

Molina-Fernández, R., Picón-Pagès, P., Barranco-Almohalla, A., Crepin, G., Herrera-Fernández, V., García-Elías, A., Fanlo-Ucar, H., Fernàndez‐Busquets, X., García‐Ojalvo, J., Oliva, B., et al. (2022) · Brain Communications · doi:10.1093/braincomms/fcac243 · Cited by 23

Study on Aβ34 biology and detection in transgenic mice brains.

Caillava, C., Ranaldi, S., Lauritzen, I., Bauer, C., Fareh, J., Abraham, J.-D., & Checler, F. (2014) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2014.01.011 · Cited by 22

Age-associated changes of cerebrospinal fluid amyloid-β and tau in cynomolgus monkeys

Yue, F., Lu, C., Ai, Y., Chan, P., & Zhang, Z. (2014) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2014.01.139 · Cited by 23

Age‐dependent NMDA receptor function is regulated by the amyloid precursor protein

Rajão‐Saraiva, J., Dunot, J., Ribera, A., Temido‐Ferreira, M., Coelho, J. E., König, S., Moréno, S., Enguita, F. J., Willem, M., Kins, S., et al. (2023) · Aging Cell · doi:10.1111/acel.13778 · Cited by 25

Multiple mechanisms of age-dependent accumulation of amyloid beta protein in rat brain: Prevention by dietary supplementation with N-acetylcysteine, α-lipoic acid and α-tocopherol

Sinha, M. S., Bir, A., Banerjee, A., Bhowmick, P., & Chakrabarti, S. (2015) · Neurochemistry International · doi:10.1016/j.neuint.2015.10.003 · Cited by 22

Protein–protein interactions in the assembly and subcellular trafficking of the BACE (β-site amyloid precursor protein-cleaving enzyme) complex of Alzheimer's disease

Parsons, R. B., & Austen, B. (2007) · Biochemical Society Transactions · doi:10.1042/bst0350974 · Cited by 22

Drosophila Full-Length Amyloid Precursor Protein Is Required for Visual Working Memory and Prevents Age-Related Memory Impairment

Rieche, F., Carmine-Simmen, K., Poeck, B., Kretzschmar, D., & Strauß, R. (2018) · Current Biology · doi:10.1016/j.cub.2018.01.077 · Cited by 25

Delta- and beta- secretases crosstalk amplifies the amyloidogenic pathway in Alzheimer’s disease

Xia, Y., Wang, Z.-H., Zhang, Z., Liu, X., Yu, S. P., Wang, J., Wang, X., & Ye, K. (2021) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2021.102113 · Cited by 21

Casein Kinase 2 dependent phosphorylation of eIF4B regulates BACE1 expression in Alzheimer’s disease

Bettegazzi, B., Monasor, L. S., Bellani, S., Codazzi, F., Restelli, L. M., Colombo, A. V., Deigendesch, N., Frank, S., Saito, T., Saido, T. C., et al. (2021) · Cell Death and Disease · doi:10.1038/s41419-021-04062-3 · Cited by 20

Suppressing UBE2N ameliorates Alzheimer's disease pathology through the clearance of amyloid beta

Zhang, C., Jia, Q., Zhu, L., Hou, J., Wang, X., Li, D., Zhang, J., Zhang, Y., Su, Y., Tu, Z., et al. (2024) · Alzheimer s & Dementia · doi:10.1002/alz.14122 · Cited by 19

Regulation of amyloid-β production by the prion protein

Jarosz-Griffiths, H., Whitehouse, I. J., & Hooper, N. M. (2012) · Prion · doi:10.4161/pri.18988 · Cited by 23

Genistein, the Isoflavone in Soybean, Causes Amyloid Beta Peptide Accumulation in Human Neuroblastoma Cell Line: Implications in Alzheimer's Disease

Chatterjee, G., Roy, D., Khemka, V. K., Chattopadhyay, M., & Chakrabarti, S. (2015) · Aging and Disease · doi:10.14336/ad.2015.0327 · Cited by 20

Upregulation of Aβ42 in the Brain and Bodily Fluids of Rhesus Monkeys with Aging

Zhao, Q., Lü, J., Yao, Z., Wang, S., Zhu, L., Wang, J., & Chen, B. (2016) · Journal of Molecular Neuroscience · doi:10.1007/s12031-016-0840-6 · Cited by 20

New players in old amyloid precursor protein‐processing pathways

Roßner, S. (2004) · International Journal of Developmental Neuroscience · doi:10.1016/j.ijdevneu.2004.07.004 · Cited by 20

Cholesterol and 24S-hydroxycholesterol trafficking in Alzheimer’s disease

Lukiw, W. J. (2006) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.6.5.683 · Cited by 20

Inflammatory insult during pregnancy accelerates age-related behavioral and neurobiochemical changes in CD-1 mice

Li, X., Wang, F., Chen, G., Li, X., Yang, Q., Cao, L., & Yan, W.-W. (2016) · AGE · doi:10.1007/s11357-016-9920-3 · Cited by 20

Modulation of γ-Secretase Activity by Multiple Enzyme-Substrate Interactions: Implications in Pathogenesis of Alzheimer's Disease

Svedružić, Ž. M., Popović, K., Smoljan, I., & Jengić, V. Š. (2012) · PLoS ONE · doi:10.1371/journal.pone.0032293 · Cited by 18

Inhibition of BACE1 affected both its Aβ producing and degrading activities and increased Aβ42 and Aβ40 levels at high-level BACE1 expression

Ulku, I., Leung, R., Herre, F., Walther, L., Shobo, A., Säftig, P., Hancock, M. A., Liebsch, F., & Multhaup, G. (2024) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2024.107510 · Cited by 20

Increased BACE1 activity inhibits peripheral nerve regeneration after injury

Tallon, C., Rockenstein, E. M., Masliah, E., & Farah, M. H. (2017) · Neurobiology of Disease · doi:10.1016/j.nbd.2017.07.003 · Cited by 18

Expression Analysis of BDNF, BACE1, and Their Natural Occurring Antisenses in Autistic Patients

Ghafouri-Fard, S., Namvar, A., Arsang-Jang, S., Komaki, A., & Taheri, M. (2020) · Journal of Molecular Neuroscience · doi:10.1007/s12031-019-01432-7 · Cited by 17

From reaction kinetics to dementia: A simple dimer model of Alzheimer’s disease etiology

Lindstrom, M. R., Chavez, M. B., Gross-Sable, E. A., Hayden, E. Y., & Teplow, D. B. (2021) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1009114 · Cited by 19

P2‐093: Age‐related modulation of gamma‐secretase activity in monkey brains

Nishimura, M., Nakamura, S., Kimura, N., Suzuki, T., & Tooyama, I. (2012) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2012.05.797

Increase of brain Aβ peptides and secretase activity during normal aging in rodent and human

Godoy-Lugo, J. A., Thorwald, M. A., Head, E., Gomm, A., Zhang, C., Tanzi, R. E., & Finch, C. E. (2025) · GeroScience · doi:10.1007/s11357-025-01926-w · Cited by 2

Age-related modulation of γ-secretase activity in non-human primate brains.

西村, 正., 中村, 紳., 遠山, 育., NISHIMURA, M., NAKAMURA, S., Kimura, N., Lei, L. I. U., Suzuki, T., & Tooyama, I. (n.d.) · Institutional Repositories DataBase (IRDB)

Changes with Age in the Activities of β‐Secretase and the Aβ‐Degrading Enzymes Neprilysin, Insulin‐Degrading Enzyme and Angiotensin‐Converting Enzyme

Miners, J. S., Helmond, Z. V., Kehoe, P. G., & Love, S. (2010) · Brain Pathology · doi:10.1111/j.1750-3639.2010.00375.x · Cited by 80

Changes in β‐secretase activity and regulation in aging and disease

Holler, C. J., Webb, R. L., Ahmed, R. R., Li, F., Beckett, T. L., & Murphy, M. P. (2009) · The FASEB Journal · doi:10.1096/fasebj.23.1_supplement.671.8